Therefore, Nrf2 is considered to be a potential therapeutic target in COPD, because it can attenuate CS-induced oxidative stress by triggering a series of cytoprotective defense mechanisms [51]. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.